Current price is less than the intrinsic value

Intrinsic value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Shares of Natco Pharma gained over 3% in a weak market today after the company received a favourable judgement from Delhi High Court in a patent infringement case of Chlorantraniliprole (CTPR) process. Natco Pharma stock rose 3.51% to Rs 599.05 today against the previous close of Rs 578.75 on BSE.

Natco Pharma stock rises 3% on favourable verdict in patent infringement case

Natco Pharma advanced 1.94% to Rs 590 after the company received a favourable judgement from Delhi High Court in a patent infringement case of Chlorantraniliprole (CTPR) process.

Natco Pharma gains on favourable verdict in CTPR patent infringement case

Key Stocks in Focus Today: HDFC, Tata Motors, Bajaj Consumer, Natco Pharma & More

Stocks to watch before going into trade today

Stocks To Watch: Adani Enterprises, Bajaj Consumer Care, Vedanta, Karur Vysya Bank, Natco Pharma

In a setback to FMC Corporation, the Delhi High Court on Monday upheld its single judge’s order that allowed Natco Pharma to roll out an insecticide Chlorantraniliprole (CTPR), saying it does not infringe the US agrochemical company’s patent.

HC upholds order allowing Natco Pharma to roll out insecticide CTPR

In May this year, Natco had announced that the corporation had filed a patent suit against it in the Delhi High Court.

Natco Pharma Receives Favourable Verdict In Patent Infringement Case

Natco Pharma receives favourable judgement in patent case

Broker’ Call: Natco Pharma (Buy)

Geojit is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 704 in its research report dated December 05, 2022.

Buy Natco Pharma; target of Rs 704: Geojit

The company is planning to complete an acquisition in the next few months

Natco Pharma mulling multiple acquisitions to boost domestic business

The suit is related to the proposed generic equivalents to Imbruvica tablets

Ibrutinib case: US court denies Natco Pharma’s partner Alvogen’s appeal

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Natco Pharma Ltd

Natco Pharma Ltd

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Natco Pharma stock rises 3% on favourable verdict in patent infringement case

Natco Pharma gains on favourable verdict in CTPR patent infringement case

Key Stocks in Focus Today: HDFC, Tata Motors, Bajaj Consumer, Natco Pharma & More

Stocks To Watch: Adani Enterprises, Bajaj Consumer Care, Vedanta, Karur Vysya Bank, Natco Pharma

HC upholds order allowing Natco Pharma to roll out insecticide CTPR

Natco Pharma Receives Favourable Verdict In Patent Infringement Case

Natco Pharma receives favourable judgement in patent case

Natco Pharma Ltd

Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Natco Pharma stock rises 3% on favourable verdict in patent infringement case

Natco Pharma gains on favourable verdict in CTPR patent infringement case

Key Stocks in Focus Today: HDFC, Tata Motors, Bajaj Consumer, Natco Pharma & More

Stocks To Watch: Adani Enterprises, Bajaj Consumer Care, Vedanta, Karur Vysya Bank, Natco Pharma

HC upholds order allowing Natco Pharma to roll out insecticide CTPR

Natco Pharma Receives Favourable Verdict In Patent Infringement Case

Natco Pharma receives favourable judgement in patent case

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock